Phosphoinositide 3-kinase in Health and Disease

, ,

À propos

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here we give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here

  • EAN

    9783642136634

  • Disponibilité

    Disponible

  • Action copier/coller

    Dans le cadre de la copie privée

  • Nb pages copiables

    1

  • Action imprimer

    Dans le cadre de la copie privée

  • Nb pages imprimables

    1

  • Partage

    Dans le cadre de la copie privée

  • Nb Partage

    6 appareils

  • Poids

    2 109 Ko

  • Distributeur

    Numilog

  • Diffuseur

    Numilog

  • Entrepôt

    Numilog

  • Support principal

    ebook (ePub)

empty